UBS AM’s Artiva Biotherapeutics ARTV Stock Holding History
Bought
Maintained
Sold
Other funds holding ARTV
UBS AM's ARTV Position: Q3 2026 in Review
UBS AM opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 33 shares worth $235. The stake represents ﹤0.01% of the portfolio and ranks #4202 among its holdings.
75 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.
- UBS AM held 33 shares of Artiva Biotherapeutics worth $235 as of Q3 2026.
- Artiva Biotherapeutics was a new UBS AM position in Q3 2026.
- Artiva Biotherapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4202 holding.
- 75 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.